001     188718
005     20210129215235.0
024 7 _ |a 10.1016/j.neuroscience.2015.02.024
|2 doi
024 7 _ |a 0306-4522
|2 ISSN
024 7 _ |a 1873-7544
|2 ISSN
024 7 _ |a WOS:000351664700006
|2 WOS
024 7 _ |a altmetric:3723926
|2 altmetric
024 7 _ |a pmid:25701708
|2 pmid
037 _ _ |a FZJ-2015-02042
082 _ _ |a 610
100 1 _ |a Walter, H. L.
|0 P:(DE-HGF)0
|b 0
|e Corresponding Author
245 _ _ |a In vivo analysis of neuroinflammation in the late chronic phase after experimental stroke
260 _ _ |a Amsterdam [u.a.]
|c 2015
|b Elsevier Science
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1426604686_15576
|2 PUB:(DE-HGF)
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|0 0
|2 EndNote
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a article
|2 DRIVER
520 _ _ |a Background and purpose: In vivo imaging of inflammatory processes is a valuable tool in stroke research. We here investigated the combination of two imaging modalities in the chronic phase after cerebral ischemia: magnetic resonance imaging (MRI) using intravenously applied ultra small supraparamagnetic iron oxide particles (USPIO), and positron emission tomography (PET) with the tracer [11C]PK11195. Methods: Rats were subjected to permanent middle cerebral artery occlusion (pMCAO) by the macrosphere model and monitored by MRI and PET for 28 or 56 days, followed by immunohistochemical endpoint analysis. To our knowledge, this is the first study providing USPIO-MRI data in the chronic phase up to 8 weeks after stroke. Results: Phagocytes with internalized USPIOs induced MRI-T2∗ signal alterations in the brain. Combined analysis with [11C]PK11195-PET allowed quantification of phagocytic activity and other neuroinflammatory processes. From 4 weeks after induction of ischemia, inflammation was dominated by phagocytes. Immunohistochemistry revealed colocalization of Iba1+ microglia with [11C]PK11195 and ED1/CD68 with USPIOs. USPIO-related iron was distinguished from alternatively deposited iron by assessing MRI before and after USPIO application. Tissue affected by non-phagocytic inflammation during the first week mostly remained in a viably vital but remodeled state after 4 or 8 weeks, while phagocytic activity was associated with severe injury and necrosis accordingly. Conclusions: We conclude that the combined approach of USPIO-MRI and [11C]PK11195-PET allows to observe post-stroke inflammatory processes in the living animal in an intraindividual and longitudinal fashion, predicting long-term tissue fate. The non-invasive imaging methods do not affect the immune system and have been applied to human subjects before. Translation into clinical applications is therefore feasible.
536 _ _ |a 572 - (Dys-)function and Plasticity (POF3-572)
|0 G:(DE-HGF)POF3-572
|c POF3-572
|x 0
|f POF III
588 _ _ |a Dataset connected to CrossRef, juser.fz-juelich.de
700 1 _ |a Walberer, M.
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Rueger, M. A.
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Backes, H.
|0 P:(DE-Juel1)162520
|b 3
700 1 _ |a Wiedermann, D.
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Hoehn, M.
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Neumaier, B.
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Graf, R.
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Fink, G. R.
|0 P:(DE-Juel1)131720
|b 8
|u fzj
700 1 _ |a Schroeter, M.
|0 P:(DE-HGF)0
|b 9
773 _ _ |a 10.1016/j.neuroscience.2015.02.024
|g Vol. 292, p. 71 - 80
|0 PERI:(DE-600)1498423-4
|p 71 - 80
|t Neuroscience
|v 292
|y 2015
|x 0306-4522
856 4 _ |u https://juser.fz-juelich.de/record/188718/files/FZJ-2015-02042.pdf
|y Restricted
909 C O |o oai:juser.fz-juelich.de:188718
|p VDB
910 1 _ |a Forschungszentrum Jülich GmbH
|0 I:(DE-588b)5008462-8
|k FZJ
|b 8
|6 P:(DE-Juel1)131720
913 0 _ |a DE-HGF
|b Gesundheit
|l Funktion und Dysfunktion des Nervensystems
|1 G:(DE-HGF)POF2-330
|0 G:(DE-HGF)POF2-333
|2 G:(DE-HGF)POF2-300
|v Pathophysiological Mechanisms of Neurological and Psychiatric Diseases
|x 0
913 1 _ |a DE-HGF
|b Key Technologies
|l Decoding the Human Brain
|1 G:(DE-HGF)POF3-570
|0 G:(DE-HGF)POF3-572
|2 G:(DE-HGF)POF3-500
|v (Dys-)function and Plasticity
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
914 1 _ |y 2015
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-3-20090406
|k INM-3
|l Kognitive Neurowissenschaften
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)INM-3-20090406
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21